About: Serum levels of hepatocyte growth factor in patients with breast cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Serum levels of hepatocyte growth factor in patients with breast cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article (publication date: March 2005)

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2005 (ast) vědecký článek publikovaný v roce 2005 (cs) 2005 թվականի մարտին հրատարակված գիտական հոդված (hy) vedecký článok (publikovaný 2005-03) (sk) 2005 թուականի Մարտին հրատարակուած գիտական յօդուած (hyw) наукова стаття, опублікована в березні 2005 (uk) مقالة علمية (نشرت في مارس 2005) (ar) wetenschappelijk artikel (gepubliceerd in 2005-03) (nl) scientific article (publication date: March 2005) (en) im März 2005 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q28239798-2550894E-2341-4EE8-BF62-4B5CDFC1E34F
publication date	2005-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28239798-403C8860-222B-4963-BF62-7B2AB3D99412
language of work or name	English
author name string	wds:Q28239798-1B1B3A8C-107F-492B-9E41-3381B3ADCC75 wds:Q28239798-47708F56-7631-416F-A2D4-C876B82388A7 wds:Q28239798-79B99F83-7436-4028-9C56-7EDAFDFEFC75 wds:Q28239798-F40625F1-1732-49DF-BDE8-7068CAE77253
OpenCitations bibliographic resource ID	wds:Q28239798-7AA08014-D720-45C3-A8E8-32BE9E7ADFD1
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/4168907
author name string	Hock-Liew Eng Shyr-Ming Sheen-Chen Fong-Fu Chou Yueh-Wei Liu
OpenCitations bibliographic resource ID	4168907
rdfs:label	Serum levels of hepatocyte growth factor in patients with breast cancer (en) Serum levels of hepatocyte growth factor in patients with breast cancer (nl) Serum levels of hepatocyte growth factor in patients with breast cancer (ast)
skos:prefLabel	Serum levels of hepatocyte growth factor in patients with breast cancer (en) Serum levels of hepatocyte growth factor in patients with breast cancer (nl) Serum levels of hepatocyte growth factor in patients with breast cancer (ast)
name	Serum levels of hepatocyte growth factor in patients with breast cancer (en) Serum levels of hepatocyte growth factor in patients with breast cancer (nl) Serum levels of hepatocyte growth factor in patients with breast cancer (ast)
title	wds:Q28239798-CAD522EA-8A6B-4AF2-9366-9E518DAF7AEE
title	Serum levels of hepatocyte growth factor in patients with breast cancer (en)
page(s)	wds:Q28239798-901A2C49-0AA1-4DF1-9F89-9B89D70ED5A7
page(s)	715-7
instance of	wds:Q28239798-0921B54D-FB5B-4C90-AFCD-5CA3EAE8E9AB
instance of	scholarly article
main subject	wds:Q28239798-8CA54C8C-2C3F-4B19-BC16-3980C5C08A24
main subject	breast cancer
PubMed ID	wds:Q28239798-04F88E5A-2B8C-45EB-95BC-3B22E9240E0A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15767355
PubMed ID	15767355
published in	wds:Q28239798-B9D7E31E-E94C-4CBA-9EAA-EF58FF9B18F7
published in	Cancer Epidemiology, Biomarkers & Prevention
issue	wds:Q28239798-A0E17A7F-BD8C-49FC-946C-820C9048B4B8
volume	wds:Q28239798-BB86382E-B5DA-40C0-84AC-B40F63F4AC03
issue	3
volume	14
DOI	wds:Q28239798-CE3903DF-0DF9-4F51-B2FB-045EEC742500
DOI	http://dx.doi.org/10.1158/1055-9965.EPI-04-0340
DOI	10.1158/1055-9965.EPI-04-0340
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28239798
is cites work of	Contribution of Adipose Tissue to Development of Cancer. Computational analysis of mRNA expression profiles identifies the ITG family and PIK3R3 as crucial genes for regulating triple negative breast cancer cell migration Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer The aromatase gene (CYP19A1) variants and circulating hepatocyte growth factor in postmenopausal women Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications. Progress of antibody-based inhibitors of the HGF-cMET axis in cancer therapy Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study. Efficacy and Mechanisms of Aerobic Exercise on Cancer Initiation, Progression, and Metastasis: A Critical Systematic Review of In Vivo Preclinical Data The unsolved chapter of vocal fold scars and how tissue engineering could help us solve the problem. Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis. Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment. Cytokines as potential tumour markers. Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer Beta-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription Plasma levels of hepatocyte growth factor and placental growth factor predict mortality in a general population: a prospective cohort study Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers Selection criteria for c-Met-targeted therapies: emerging evidence for biomarkers
is cites work of	wds:Q36623385-99506FFA-4CCB-4F8C-A10C-63EE385C6FBA wds:Q31112729-D94B4F78-7341-4681-BA39-8E975CBEBBC1 wds:Q37523867-87C0CC32-2078-428C-B92B-75967ACF6B90 wds:Q51382532-F366AADB-9F8A-475E-B16B-AE03BB7C95B3 wds:Q36169304-AF7A296B-D8BB-435C-951F-11F7866511BA wds:Q36848899-85FFD33F-ADA6-4598-BDAD-077409FE463B wds:Q33657062-CFD125A0-BDE1-4006-8A22-8323B6AC44E2 wds:Q37739477-95E31DA4-0CD8-4504-AFDE-BD4F909B022A wds:Q55235695-98A0C0F1-CB18-43B8-9231-03B8F1072588 wds:Q31120913-78F33F3E-3939-40BE-AB5F-EC2015554971 wds:Q36788273-0051F5EB-CA7D-44D5-8412-FEC03D96DDFB wds:Q38691253-D2C10399-8A93-40C4-AC7E-0A8D437F6FF7 wds:Q38537078-C30CE9DD-C492-443C-AF65-1646052B391A wds:Q26775189-86F50D0F-195C-4BC4-B48D-C54CB5118136 wds:Q61806379-BF67EC7A-C108-46A2-BABD-4279A0B01E92 wds:Q57791826-FE607E72-7027-4087-A3BD-65A64A4B7B44 wds:Q50985091-585C26AF-30E1-446B-8A6E-8702C3B104B5 wds:Q35834584-219C5EE3-7E77-43C2-B6FA-8A313B1A7556 wds:Q34359484-9FC088BF-8993-4773-939B-9B0F9B93FECB

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software